How Will the Market React to Thermo Fisher Scientific Inc. (TMO) Stock Getting a Bullish Rating

Overall market sentiment has been high on Thermo Fisher Scientific Inc. (TMO) stock lately. TMO receives a Bullish rating from InvestorsObserver Stock Sentiment Indicator.

Thermo Fisher Scientific Inc. has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on TMO!

See Full TMO Report

What is Stock Sentiment?

Sentiment uses short term technical analysis to gauge whether a stock is desired by investors. As a technical indicator, it focuses on recent trends as opposed to the long term health of the underlying company. Updates for the company such as a earnings release can move the stock away from current trends. Recent trends are a good indicator of current market sentiments. In its most basic form, stocks that are trending up are desirable by investors while stocks currently falling must be unattractive. InvestorsObserver's Sentimental Indicator tracks both changes in price and volume to analyze the most recent trends. Typically an increase in volume indicates ongoing trends are getting stronger, while a decrease in volume usually signals an end to the current trend. Available options can also represent current sentiments for a given stock. Since investors are able to bet on future trends of stocks using options, we consider the ratio of calls to puts when analyzing market sentiments .

What's Happening With TMO Stock Today?

Thermo Fisher Scientific Inc. (TMO) stock is trading at $579.35 as of 1:03 PM on Tuesday, Jan 24, a decline of -$25.45, or -4.21% from the previous closing price of $604.80. The stock has traded between $577.20 and $609.85 so far today. Volume today is less active than usual. So far 1,046,840 shares have traded compared to average volume of 1,613,844 shares. To screen for more stocks like Thermo Fisher Scientific Inc. click here.

More About Thermo Fisher Scientific Inc.

Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of mid-2022 (revenue figures include some cross-segment revenue): analytical technologies (15% of sales); specialty diagnostic products (10%); life science solutions (30%); and lab products and services, which includes CRO services (51%). Click Here to get the full Stock Report for Thermo Fisher Scientific Inc. stock.